Authors
Philippe Garot, Jens Erik Nielsen-Kudsk, Ole De Backer
Published in
European heart journal. Valvular and structural heart disease. Volume 2. Issue 3. Pages xwag049. Epub Jun 18, 2026.
Abstract
Graphical AbstractA critical review of the CLOSURE-AF trial and lessons learned. Concerns about patient selection (bias), procedural safety and post-procedural medical therapy are raised. The CLOSURE-AF trial mainly enrolled high-risk, multi-morbid patients, for whom LAAC did not yield net clinical benefit compared with OAC therapy. LAAC, left atrial appendage closure; OAC, oral anticoagulant.For image description, please refer to the figure legend and surrounding text.
PMID:
43053895
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0